Michael J. Overman
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 263
- Colorectal Cancer Treatments and Studies 154
- Cancer Immunotherapy and Biomarkers 66
- Pancreatic and Hepatic Oncology Research 47
-
- Genetic factors in colorectal cancer 99
- Co-authors
- Scott Kopetz (223 shared papers)Cathy Eng (86 shared papers)Robert A. Wolff (126 shared papers)Sara Lonardi (35 shared papers)Thierry André (28 shared papers)Heinz‐Josef Lenz (23 shared papers)Andrew Hill (14 shared papers)Rebecca A. Moss (13 shared papers)
- Journals
- Journal of Clinical Oncology (191 papers)Annals of Oncology (28 papers)The Oncologist (13 papers)Clinical Cancer Research (13 papers)Clinical Colorectal Cancer (13 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Michael J. Overman
431 papers receiving 16.7k citations
Michael J. Overman's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 8.9k
- Hepatology 1.8k
- Pathology and Forensic Medicine 3.1k
- Gastroenterology 918
- Cancer Research 2.4k
Countries citing papers authored by Michael J. Overman
This map shows the geographic impact of Michael J. Overman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Overman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Overman more than expected).
Fields of papers citing papers by Michael J. Overman
This network shows the impact of papers produced by Michael J. Overman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Overman. The network helps show where Michael J. Overman may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Overman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 454 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Hit paper breakdown → | 2017 | 2014 |
| 2 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer Hit paper breakdown → | 2018 | 1455 |
| 3 | Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy Hit paper breakdown → | 2009 | 1014 |
| 4 | Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases Hit paper breakdown → | 2008 | 431 |
| 5 | 2009 | 378 | |
| 6 | Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 Hit paper breakdown → | 2019 | 378 |
| 7 | 2011 | 275 | |
| 8 | 1995 | 263 | |
| 9 | 2019 | 258 | |
| 10 | 2012 | 249 | |
| 11 | 2011 | 243 | |
| 12 | Clinical and molecular characterization of early‐onset colorectal cancer Hit paper breakdown → | 2019 | 242 |
| 13 | 2017 | 204 | |
| 14 | 2014 | 203 | |
| 15 | 2014 | 194 | |
| 16 | 2015 | 188 | |
| 17 | 2010 | 179 | |
| 18 | 2010 | 175 | |
| 19 | 2009 | 175 | |
| 20 | Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 Hit paper breakdown → | 2022 | 167 |
About Michael J. Overman
Michael J. Overman is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 454 papers that have together received 16.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (154 papers), Genetic factors in colorectal cancer (99 papers), Cancer Genomics and Diagnostics (87 papers), Cancer Immunotherapy and Biomarkers (66 papers), Pancreatic and Hepatic Oncology Research (47 papers), Intraperitoneal and Appendiceal Malignancies (35 papers), Gastric Cancer Management and Outcomes (34 papers) and Gastrointestinal Tumor Research and Treatment (33 papers). The work is most often cited by research in Oncology (8.9k citations), Hepatology (1.8k citations), Pathology and Forensic Medicine (3.1k citations), Gastroenterology (918 citations) and Cancer Research (2.4k citations). Michael J. Overman has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Scott Kopetz, Cathy Eng, Robert A. Wolff, Sara Lonardi, Thierry André, Heinz‐Josef Lenz, Andrew Hill, Rebecca A. Moss, Jean-Marie Ledeine and Jean‐Nicolas Vauthey. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Oncologist, Clinical Cancer Research and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.